Results 31 to 40 of about 48,653 (304)
Бюллетень сибирской медицины, 2015 The purpose of the present work was to study the clinical features and risk factors of tardive dyskinesia among the schizophrenia patients who durably receive the antipsychotic therapy.
Ye. G. Kornetova +4 more
doaj +1 more source
ATP Signaling Controlling Dyskinesia Through P2X7 Receptors
Frontiers in Molecular Neuroscience, 2020 Dopamine replacement therapy with L-3,4-dihydroxyphenylalanine (L-DOPA) is the only temporary therapy for Parkinson’s disease (PD), but it triggers dyskinesia over time.
Analu A. Fonteles +8 more
doaj +1 more source
Post-cholecystectomy syndrome: A new look at an old problem
Journal of Minimal Access Surgery, 2018 Background: Despite being the most commonly performed operations, sometimes cholecystectomy fails to relieve symptoms; this is now a well-recognised clinical entity termed 'post-cholecystectomy syndrome' (PCS).
Divya Arora +3 more
doaj +1 more source
Rare form of dyskinetic movements associated with alcohol withdrawal
Indian Journal of Psychological Medicine, 2016 Movement disorders are known to occur during alcohol withdrawal. Tremor, choreoathetosis, transient parkinsonism, myoclonus and dystonia have been previously described. The present report describes involuntary ′fluttering′ movements of fingers developing
Sathya Prakash, Yatan Pal Singh Balhara
doaj +1 more source
Frontiers in Neurology, 2021 Background: Clinical trials for antiparkinsonian drugs aimed at managing motor complications typically use patient diaries to divide levodopa-induced dyskinesias (LID) into “troublesome” and “non-troublesome” categories.
Robert A. Hauser +4 more
doaj +1 more source
, 2003 Although the pathophysiological defect in primary ciliary dyskinesia (PCD; Siewert's/Kartagener's syndrome) is now well characterised, there are few studies of the impact of the condition upon health function, particularly in later life.
I Christopher McManus +14 more
core +1 more source
Diagnosis of Primary Ciliary Dyskinesia [PDF]
, 2022 Primary ciliary dyskinesia (PCD) is a rare genetic disease leading to bronchiectasis in most patients. In addition to the lungs, PCD might affect multiple organ systems, and patients frequently have multiple clinical problems, which require ...
Shoemark, Amelia; id_orcid +2 more
core +1 more source
Levosulpiride-induced neurological adverse effects: A prospective study from a tertiary care center
Annals of Indian Academy of Neurology, 2020 Background: Levosulpiride (LS) is a prokinetic drug increasingly used for the gastric motility disorders. Despite its common use for the gastric motility disorder, the tendency to cause parkinsonism and acute dystonias are under-recognized as the major ...
Jacob Joe
doaj +1 more source
Primary ciliary dyskinesia: current state of the art
, 2007 Primary ciliary dyskinesia (PCD) is usually inherited as an autosomal recessive, and in classical form presents with upper and lower respiratory tract infection, and mirror image arrangement in around 50% cases.
Hall, Pippa +10 more
core +1 more source